NeuroSafe Medical Co., Ltd.

On October 16, Russia customers conducted a comprehensive and in-depth investigation of NeuroSafe Medical, and highly praised the company's continuous R&D innovation capabilities and product manufacturing strength. The two sides also had a candid and fruitful exchange on the future prospects of strategic cooperation, and jointly explored new space and new opportunities for cooperation in the medical field. In order to help customers better understand the products, the company's R&D team introduced in detail the various intracranial neurointervention products that NeuroSafe is selling and developing, and demonstrated related products. After in-depth communication and exchanges, Russia customers signed an agreement with NeuroSafe Medical. This cooperation is not only an important step in vigorously expanding overseas markets, but also pushing NeuroSafe Medical's high-quality products to a broader international stage. 

On October 12, Kazakhstan customers conducted a comprehensive and in-depth investigation of NeuroSafe Medical, and highly praised the company's continuous R&D innovation capabilities and product manufacturing strength. The two sides also had a candid and fruitful exchange on the future prospects of strategic cooperation, and jointly explored new space and new opportunities for cooperation in the medical field. In order to help customers better understand the products, the company's R&D team introduced in detail the various intracranial neurointervention products that NeuroSafe is selling and developing, and demonstrated related products. After in-depth communication and exchanges, NeuroSafe Medical officially hired Dr. Azat Shpekov as the company's special medical consultant. This cooperation is not only an important step in vigorously expanding overseas markets, but also pushing NeuroSafe Medical's high-quality products to a broader international stage. At the same time, it will also inject new vitality into the development of Kazakhstan's medical industry and bring more treatment options and hope to local patients.

Good news！ NeuroSafe's Glutton Aspiration Catheter has developed three new models, which are used to match BGC. As long as BGC with ID≥ 0.084", our Glutton Aspiration Catheter of BGC models are compatible.

We’re exhibiting at the LINNC Seminar 2024 - Asia! From 25 to 26 October 2024, we will be showcasing our latest innovations in medical technology and solutions at the LINNC Seminar 2024 - Asia, a Interventional Neuroradiology, Neurosurgery and Neurology Seminar in Bangkok, Thailand.   Visit our booth to explore how we're providing comprehensive solutions for neurointerventional field. Our teams are ready to welcome you!   📍 the Renaissance Bangkok Ratchaprasong Hotel, Thailand. 📅25– 26 October 2024 We look forward to seeing you here!

A clinical trial using LAVA Liquid Embolic System. Patient: Male, 33 years old, previously healthy. Main complaint: intermittent dizziness for 2 years, aggravated for 1 week. Current medical history: MRI+MRA showed left frontal arteriovenous malformation. Neurological examination after admission: clear consciousness, good spirit, clear awareness, fluent speech, normal limb muscle strength, normal muscle tone, negative bilateral pathological signs, negative meningeal irritation signs. Feedback from clinical trial doctors: Lava liquid embolic system has excellent visualization and diffusion. When the microcatheter cannot penetrate the lesion, it can diffuse to a farther part to complete the embolization. Compared with the doctor's own dilution embolic agent, the effect for Lava is more stable. When combined with embolization of DAVF, Lava has a better diffusion advantage, and uses more micronized grain size of tantalum powder, which has better visualization. The resistance is smaller when inject with Lava liquid embolic system.

We Will Participate LINNC Seminar 2024 Asia in Bangkok, Thailand from October 25th to 26th. Welcome to our booth#6 to learn more about neuro intervention device. We are looking forward to see you there!

New case for Dredger stent retriever.

A new case for Dredger Stent Retriever with full-length visibility from@NeuroSafe Medical Co., Ltd.

It is excited to share a new case successfully treated in Kazakhstan with Lava Liquid Embolic System from NeuroSafe Medical Co., Ltd.

The Lava™ liquid embolic system for peripheral embolization consists of an elastic polymer consisting of an ethylene vinyl alcohol (EVOH) copolymer dissolved in dimethyl sulfoxide (DMSO) and made radiolucent by the addition of micronized tantalum powder. Lava™ is a liquid, non-adhesive, non-absorbable, injectable and permanent embolic agent. Due to its non-adhesive physical properties, it is easy to administer as the risk of sticking to a microcatheter tip is low. Its viscosity contributes to correct administration. Due to its physical properties, Lava™ has better embolic predictability than other currently available liquid agents and has good potential for endovascular bleeding management.